Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Did RG /crossflo deal...

Aug 25, 2008 10:39AM
6
Aug 26, 2008 10:08AM
3
Aug 26, 2008 11:34AM
1
Aug 26, 2008 11:53AM
4
Aug 26, 2008 12:00PM

Aug 26, 2008 12:17PM
18
Aug 26, 2008 12:28PM

Aug 26, 2008 01:31PM

Aug 26, 2008 01:39PM

Aug 26, 2008 01:47PM

Aug 26, 2008 02:11PM
5
Aug 26, 2008 03:45PM

Aug 26, 2008 07:49PM

I don't think we can assume that Crossflo would accept the cash equivalent based on current pps level. What if Crossflo wanted $1.00 for each share? If that was the case and PTSC felt Crossflo was worth that much to them, (the presentation assigns very high importance) then is the use of shares purchased at $.55 an issue? If they want to conserve cash, and they are getting (for arguments sake) a $1.00 value for each share, then its a good deal. Yes?

Looking at it this way is less stressful, and perhaps is exactly the way RG is looking at it. Opty



1
Aug 27, 2008 04:47AM

Aug 27, 2008 05:01AM
Share
New Message
Please login to post a reply